Car-T and Bispecific Antibodies for Refractory Non-Hodgkin Lymphoma: Long-Term Safety and Autoimmune Sequelae. Journal of Carcinogenesis, [S. l.], v. 24, n. 6s, p. 805–820, 2025. DOI: 10.64149/J.Carcinog.24.6s.805-820. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/1781. Acesso em: 18 mar. 2026.